Why is CRISIL falling/rising?

Recent Price Movement and Market Comparison

CRISIL’s share price has been under pressure over multiple time frames. In the past week, the stock declined by 3.10%, contrasting sharply with the Sensex’s modest gain of 0.10%. Over the last month, the divergence widened further, with CRISIL falling 11.66% while the Sensex rose 1.11%. Year-to-date, the stock has plummeted 33.50%, a stark contrast to the Sensex’s 9.70% appreciation. Even over the one-year horizon, CRISIL’s shares have lost 15.95%, whereas the benchmark index gained 6.84%. Although the stock has outperformed the Sensex over three and five years with returns of 48.97% and 124.93% respectively, this longer-term strength has not shielded it from recent weakness.

Trading Dynamics and Technical Indicators

On the day in question, CRISIL underperformed its sector by 0.32%, touching an intraday low of ₹4,427.15, down 2.26%. The weighted average price indicates that a larger volume of shares traded near the day’s low, signalling selling pressure. Technically, the stock is trading below all major moving averages—5-day, 20-day, 50-day, 100-day, and 200-day—highlighting a bearish trend. Investor participation has also waned, with delivery volumes on 26 Nov falling by 35.93% compared to the five-day average, suggesting reduced conviction among buyers. Despite this, liquidity remains adequate for moderate trade sizes, with a 2% threshold of the five-day average traded value supporting transactions up to ₹0.34 crore.

Fundamental Performance and Valuation Concerns

While CRISIL boasts a high management efficiency, reflected in a return on equity (ROE) of 29.44%, and maintains a conservative capital structure with an average debt-to-equity ratio of zero, its growth metrics have raised investor caution. Over the past five years, net sales have grown at a modest annual rate of 13.49%, with operating profit expanding at 19.79%. However, the company reported flat results in the September 2025 quarter, which may have dampened market enthusiasm.

The valuation appears stretched, with a price-to-book value ratio of 11.5, indicating that the stock is priced expensively relative to its book value. Although this valuation is in line with peers’ historical averages, it remains high in absolute terms. The company’s ROE of 25.8% further underscores its profitability, yet the price-earnings-to-growth (PEG) ratio stands at 3.7, signalling that earnings growth may not justify the current price level. This disconnect between profit growth—up 11.9% over the past year—and share price performance, which declined nearly 16%, suggests that investors are factoring in concerns about future growth prospects and valuation sustainability.

Comparative Performance and Investor Sentiment

CRISIL’s underperformance extends beyond short-term fluctuations. It has lagged the broader BSE500 index over the last three years, one year, and three months, indicating persistent challenges in delivering market-beating returns. This below-par performance, combined with flat recent earnings and expensive valuation metrics, has likely contributed to subdued investor sentiment and selling pressure.

Conclusion

In summary, CRISIL’s recent share price decline on 27-Nov is attributable to a combination of factors including disappointing short-term earnings, a high valuation that may not be supported by growth prospects, and technical indicators signalling bearish momentum. Despite strong management efficiency and a clean balance sheet, the stock’s underperformance relative to benchmarks and peers has weighed on investor confidence. The subdued delivery volumes and trading near intraday lows further reinforce the cautious stance among market participants. Investors should carefully weigh these factors against the company’s long-term fundamentals before considering fresh exposure.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →